Download PDF
Am J Perinatol 2005; 22(2): 115-120
DOI: 10.1055/s-2005-837276
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Risk Factors of Retinopathy of Prematurity in Premature Infants Weighing Less Than 1600 g

Po-Mai Liu1 , 4 , Po-Chiung Fang2 , Chung-Bin Huang1 , His-Kung Kou2 , Mei-Yung Chung1 , Yi-Hsin Yang3 , Ching-Hung Chung5
  • 1Department of Pediatrics, Division of Neonatology, Chang Gung Children's Hospital, Kaohsiung, Taiwan
  • 2Department of Ophthalmology, Chang Gung Children's Hospital, Kaohsiung, Taiwan
  • 3Graduate Institute of Oral Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan
  • 4Department of Pediatrics, E-Da Hospital, Kaohsiung, Taiwan
  • 5Dental Department, E-Da Hospital, Kaohsiung, Taiwan
Further Information

Publication History

Publication Date:
10 February 2005 (online)

    Permissions and Reprints

ABSTRACT

There are many risk factors contributing to retinopathy of prematurity (ROP). Some are still controversial, including the use of glucocorticoid and intraventricular hemorrhage. Hence, a retrospective study was performed to evaluate the association between the suspected risk factors and ROP in a medical center in southern Taiwan. One hundred fifty-nine infants with birth body weight < 1600 g admitted to our neonatal intensive care unit before the 29th day of life were enrolled into this study. Clinical data were analyzed by means of logistic regression. The prevalence of ROP in all infants (birthweight < 1600 g) is 36.48% (58 of 159) and 59.46% (22 of 37) in extremely low birthweight infants (birthweight ≤ 1000 g). One infant with gestational age 32 weeks and birthweight 1420 g developed stage III ROP. Logistic regression revealed six factors to be significant variables. Birthweight ≤ 1000 g, intraventricular hemorrhage, sepsis, and use of glucocorticoid or dopamine were risk factors associated with higher incidence of ROP. Supplementation of vitamin E was shown to relate to lower incidence of ROP. This study confirms several risk factors recognized in previous statistical analyses. Sepsis is the most significant factor contributing to ROP. Vitamin E was proven to be effective in prophylaxis of development of ROP. The possibility of development of ROP could not be excluded in infants with gestational age > 32 weeks.

KEYWORDS

Retinopathy of prematurity - extremely low birthweight - sepsis

REFERENCES

  • 1 Bossi E, Koerner F. Retinopathy of prematurity.  Intensive Care Med. 1995;  21 241-246
    CrossrefPubMedGoogle Scholar
  • 2 Lucey J F, Dangman B. A re-examination of the role of oxygen in retrolental fibroplasia.  Pediatrics. 1984;  73 82-96
    PubMedGoogle Scholar
  • 3 Liao S L, Lai S H, Kuo C Y. Effect of carbon dioxide tension in the first three days of life on the development of retinopathy of prematurity.  Chang Gung Med J. 2000;  23 755-760
    PubMedGoogle Scholar
  • 4 Dani C, Reali M F, Bertini G, Martelli E, Pezzati M, Rubaltelli F F. The role of blood transfusions and iron intake on retinopathy of prematurity.  Early Hum Dev. 2001;  62 57-63
    CrossrefPubMedGoogle Scholar
  • 5 O'Keefe M, Kafil-Hussain N, Flitcroft I, Lanigan B. Ocular significance of intraventricular hemorrhage in premature infants.  Br J Ophthalmol. 2001;  85 357-359
    CrossrefPubMedGoogle Scholar
  • 6 Brooks S E, Marcus D M, Gillis D, Pirie E, Johnson C S, Bhatia J. The effect of blood transfusion protocol on retinopathy of prematurity: a prospective, randomized study.  Pediatrics. 1999;  104 514-518
    CrossrefPubMedGoogle Scholar
  • 7 Holmstrom G, Broberger U, Thomassen P. Neonatal risk factors for retinopathy of prematurity-a population-based study.  Acta Ophthalmol Scand. 1998;  76 204-207
    Google Scholar
  • 8 The Committee for the Classification of Retinopathy of Prematurity . An international classification of retinopathy of prematurity.  Arch Ophthalmol. 1984;  102 1130-1134
    CrossrefPubMedGoogle Scholar
  • 9 Teng R J, Wu T J, Yau K I. Retinopathy of prematurity in very-low-birthweight neonates: epidemiology and risk factors.  Acta Paed Sin. 1997;  38 370-374
    PubMedGoogle Scholar
  • 10 Chou Y H, Teng R J, Yau K I, Yang C M. Retinopathy of prematurity: an analysis of risk factors.  J Formos Med Assoc. 1993;  92 440-445
    PubMedGoogle Scholar
  • 11 Mathew M R K, Fern A L, Hill R. Retinopathy of prematurity: are we screening too many babies?.  Eye. 2002;  16 538-542
    CrossrefPubMedGoogle Scholar
  • 12 Larsson E, Holmstrom G. Screening for retinopathy of prematurity: evaluation and modification of guidelines.  Br J Ophthalmol. 2002;  86 1399-1402
    CrossrefPubMedGoogle Scholar
  • 13 The Italian ROP Study Group . Italian multicentre study on retinopathy of prematurity.  Eur J Pediatr. 1997;  156 939-943
    CrossrefPubMedGoogle Scholar
  • 14 Lee S. Retinopathy of prematurity in the 1990s.  Neonatal Netw. 1999;  18 31-38
    PubMedGoogle Scholar
  • 15 Hardy P, Dumont I, Bhattacharya M et al.. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy.  Cardiovasc Res. 2000;  47 489-509
    CrossrefPubMedGoogle Scholar
  • 16 Schaffer D B, Palmer E A, Plotsky D F et al.. Prognostic factors in the natural course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group.  Ophthalmology. 1993;  100 230-237
    Google Scholar
  • 17 Gallo J E, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity.  Acta Paediatr. 1993;  82 829-834
    PubMedGoogle Scholar
  • 18 Charles J B, Ganthier R, Appiah A P. Incidence and characteristics of retinopathy of prematurity in a low-income inner-city population.  Ophthalmology. 1991;  98 14-17
    PubMedGoogle Scholar
  • 19 Gunn T R, Easdown J, Outerbridge E W, Aranda J V. Risk factors in retrolental fibroplasias.  Pediatrics. 1980;  65 1096-1100
    PubMedGoogle Scholar
  • 20 Purohit D M, Ellison R C, Zierler S, Miettinen O S, Nadas A S. Risk factors for retrolental fibroplasias: experience with 3,025 premature infants. National collaborative study on patent ductus arteriosus in premature infants.  Pediatrics. 1985;  76 339-344
    PubMedGoogle Scholar
  • 21 Brown D R, Biglan A W, Stretavsky M M. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia.  J Pediatr Ophthalmol Strabismus. 1990;  27 268-271
    PubMedGoogle Scholar
  • 22 Procianoy R S, Garcia-Prats J A, Hittner H M, Adams J M, Rudolph A J. An association between retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants.  Acta Paediatr Scand. 1981;  70 473-477
    PubMedGoogle Scholar
  • 23 Brown D R, Milley J R, Ripepi U J, Biglan A W. Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates.  Am J Dis Child. 1987;  141 154-160
    PubMedGoogle Scholar
  • 24 Whitelaw A. Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions.  Semin Neonatol. 2001;  6 135-146
    CrossrefPubMedGoogle Scholar
  • 25 Kelly F J. Free radical disorders of preterm infants.  Br Med Bull. 1993;  49 668-678
    CrossrefPubMedGoogle Scholar
  • 26 Termote J, Schalij-Delfos N E, Brouwers H A, Donders A R, Cats B P. New developments in neonatology: less severe retinopathy of prematurity?.  J Pediatr Ophthalmol Strabismus. 2000;  37 142-148
    PubMedGoogle Scholar
  • 27 Kretzer F L, Hittner H M. Retinopathy of prematurity: clinical implications of retinal development.  Arch Dis Child. 1988;  63 1151-1167
    PubMedGoogle Scholar
  • 28 Johnson L, Quinn G E, Abbasi S et al.. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.  J Pediatr. 1989;  114 827-838
    PubMedGoogle Scholar
  • 29 Penn J S, Rajaratnam V S, Collier R J, Clark A F. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.  Invest Ophthalmol Vis Sci. 2001;  42 283-290
    PubMedGoogle Scholar
  • 30 Danis R P, Bingaman D P, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.  Ophthalmology. 1996;  103 2099-2104
    PubMedGoogle Scholar
  • 31 Rotschild T, Nandgaonkar B N, Yu K, Higgins R D. Dexamethasone reduces oxygen induced retinopathy in a mouse model.  Pediatr Res. 1999;  46 94-100
    CrossrefPubMedGoogle Scholar
  • 32 Ramanathan R, Siassi B, deLemos R A. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.  J Perinatol. 1995;  15 178-182
    PubMedGoogle Scholar
  • 33 Haroon Parupia M F, Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.  J Perinatol. 2001;  21 242-247
    CrossrefPubMedGoogle Scholar
  • 34 Termote J, Schalij-Delfos N E, Donders A R, Cats B P. Do postnatal glucocorticoids and retinopathy of prematurity relate?.  Am J Perinatol. 2000;  17 291-298
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Halliday H L, Ehrenkranz R A, Doyle L W. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Available at: http://156.40.88.3/cochrane/hallida3/halliday.htm
    Google Scholar
  • 36 Halliday H L, Ehrenkranz R A, Doyle L W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Available at: http://156.40.88.3/cochrane/hallida2/halliday.htm
    Google Scholar
  • 37 Halliday H L, Ehrenkranz R A, Doyle L W. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Available at: http://156.40.88.3/cochrane/hallida4/halliday.htm
    Google Scholar
  • 38 Mizoguchi M B, Chu T G, Murphy F M, Willits N, Morse L S. Dopamine use is an indicator for the development of threshold retinopathy of prematurity.  Br J Ophthalmol. 1999;  83 425-428
    PubMedGoogle Scholar

Mei-Yung ChungM.D. 

Department of Pediatrics, Chang Gung Children's Hospital

123, Ta Pei Road, Niao Sung Hsiang, Kaohsiung Hsien 833

Taiwan, Republic of China

      >